News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Axikin Pharmaceuticals and Proteros Enter into Fragment-Based Lead Discovery Collaboration


3/30/2009 8:57:28 AM

SAN DIEGO, Calif. & MUNICH, Germany--(BUSINESS WIRE)--Axikin Pharmaceuticals (“Axikin”), San Diego, CA, U.S.A. and Proteros fragments (“Proteros”), Munich, Germany, a specialist structure-based lead discovery company, are pleased to announce today that they have entered into a significant research service collaboration to discover novel, customized lead compounds for the treatment of inflammatory diseases.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES